Most womb cancers start in glandular cells found in the lining of the womb (the endometrium). These are called endometrial cancers. These are the most common type of womb cancer. They are usually diagnosed early and treated successfully. This information is about endometrial cancers.
There are different types of endometrial cancer:
- endometrioid cancer
- serous endometrial carcinoma (also called uterine serous carcinoma)
- carcinosarcoma (these cancers are not sarcomas, despite their name)
- clear cell carcinoma
- mucinous carcinoma
- mixed cell endometrial cancer.
About 3 out of 4 womb cancers (75%) are endometrioid cancers. They are usually grade 1 or grade 2 and are diagnosed at an early stage. The womb is sometimes also called the uterus.
Type 1 endometrial cancers
These cancers are slow growing and are usually diagnosed at an early stage. They include grade 1 and grade 2 endometrioid cancers and all mucinous cancers.
Type 2 endometrial cancers
These cancers are always high-grade (grade 3) and usually grow more quickly. They include:
- serous endometrial carcinoma
- clear cell carcinoma
- grade 3 endometrioid cancers
- mixed cell endometrial cancers.
Below is a sample of the sources used in our womb cancer information. If you would like more information about the sources we use, please contact us at email@example.com
Concin et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. International Journal of Clinical Oncology. 2021. Available from www.pubmed.ncbi.nlm.nih.gov/33397713/
Royal College of Radiotherapy: Clinical Oncology. Radiotherapy dose fractionation, third edition. 2019. Available from www.rcr.ac.uk/publication/radiotherapy-dose-fractionation-third-edition
Sundar et al. BGCS uterine cancer guidelines: Recommendations for practice. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2017. Available from www.bgcs.org.uk/wp-content/uploads/2019/05/BGCSEndometrial-Guidelines-2017.pdf
This information has been written, revised and edited by Macmillan Cancer Support’s Cancer Information Development team. It has been reviewed by expert medical and health professionals and people living with cancer. It has been approved by Senior Medical Editor, Professor Nick Reed, Consultant Clinical Oncologist.
Our cancer information has been awarded the PIF TICK. Created by the Patient Information Forum, this quality mark shows we meet PIF’s 10 criteria for trustworthy health information.
The language we use
We want everyone affected by cancer to feel our information is written for them.
We try to make sure our information is as clear as possible. We use plain English, avoid jargon, explain any medical words, use illustrations to explain text, and make sure important points are highlighted clearly.
We use gender-inclusive language and talk to our readers as ‘you’ so that everyone feels included. Where clinically necessary we use the terms ‘men’ and ‘women’ or ‘male’ and ‘female’. For example, we do so when talking about parts of the body or mentioning statistics or research about who is affected. Our aims are for our information to be as clear and relevant as possible for everyone.
You can read more about how we produce our information here.